InvestorsHub Logo
Followers 89
Posts 17480
Boards Moderated 0
Alias Born 09/06/2006

Re: newman2021 post# 556794

Thursday, 01/05/2023 2:09:30 PM

Thursday, January 05, 2023 2:09:30 PM

Post# of 705356
Speaking of the "helmet scam", people may have missed that the LUNAR trial was also stat sig for TTF+CI vs CI.

In short, NVCR has a CI combo that will very likely be approved in about a year.

This might bode well for NVCR's GBM program in combo with CIs where they are already more advanced than NWBO.
. 2TheTop (Keytruda/P1/rGBM) completed
. Keynote B36 (P2/Keytruda/rGBM) is enrolling
. Keynote D58 (P3/Keytruda/nGBM) is planned

Also have a combo trial agreement with Roche for Tencentriq in pancreatic

Amazing how BPs and RAs fail to see the scam that you see.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News